ALPS Medical Breakthroughs ETF (SBIO) Holdings List

$52.76 0.00 (0.00%)

As of 06/12/2026 04:10 PM Eastern

What stocks does SBIO hold?

The ALPS Medical Breakthroughs ETF (SBIO) top stock holdings include Alkermes, Kymera Therapeutics, and Spyre Therapeutics. The top 25 SBIO holdings ordered by weight make up 63.55% of the total fund. SBIO is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete SBIO stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 SBIO Holdings

Rank	Company	Current Price	Weight	Shares Held
1	ALKS Alkermes	$44.28	4.84%	170,280
2	KYMR Kymera Therapeutics	$86.21	4.06%	83,447
3	SYRE Spyre Therapeutics	$80.79	3.93%	80,278
4	MIRM Mirum Pharmaceuticals	$99.35	3.77%	61,677
5	APGE Apogee Therapeutics	$88.33	3.21%	57,237
6	CGON CG Oncology	$59.56	3.12%	86,301
7	XENE Xenon Pharmaceuticals	$52.10	3.02%	85,026
8	TVTX Travere Therapeutics	$52.04	2.83%	94,252
9	CELC Celcuity	$88.55	2.80%	47,292
10	EWTX Edgewise Therapeutics	$34.83	2.64%	109,647
Get the Latest News and Ratings for SBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.
11	DNTH Dianthus Therapeutics	$82.07	2.57%	45,454
12	NAMS NewAmsterdam Pharma	$30.40	2.51%	117,518
13	ACAD ACADIA Pharmaceuticals	$21.09	2.48%	174,264
14	CRNX Crinetics Pharmaceuticals	$34.47	2.35%	106,985
15	VKTX Viking Therapeutics	$28.75	2.30%	118,107
16	DNLI Denali Therapeutics	$21.66	2.12%	162,094
17	ORKA Oruka Therapeutics	$69.89	1.88%	49,477
18	RLAY Relay Therapeutics	$14.81	1.86%	182,676
19	IRON Disc Medicine	$67.99	1.83%	39,004
20	GPCR Structure Therapeutics	$42.93	1.81%	72,407
21	TARS Tarsus Pharmaceuticals	$61.95	1.70%	43,502
22	IDYA IDEAYA Biosciences	$28.98	1.70%	89,760
23	VERA Vera Therapeutics	$34.26	1.52%	72,934
24	MLYS Mineralys Therapeutics	$23.62	1.35%	80,893
25	CLDX Celldex Therapeutics	$31.27	1.35%	68,039

SBIO Geographic Exposure

SBIO's largest geographic exposure is United States at 85.9%, followed by Ireland at 5.0%.

United States
85.9%
Ireland
5.0%
Netherlands
3.1%
Canada
2.9%
Cayman Islands
1.6%

SBIO Currency Exposure

SBIO is exclusively exposed to USD.

USD
100.0%

SBIO Sector Exposure

SBIO's largest sector exposure is Health Care at 99.0%, followed by Energy at 0.6%.

Health Care
99.0%
Energy
0.6%
Consumer Discretionary
0.2%

SBIO Industry Exposure

SBIO's largest industry exposure is Biotechnology at 81.7%, followed by Pharmaceuticals at 12.6%.

Biotechnology
81.7%
Pharmaceuticals
12.6%
Diversified Consumer Services
3.0%
Health Care Equipment & Supplies
1.6%
Renewable Energy
0.6%
Health Care Providers & Services
0.4%

SBIO Sub-Industry Exposure

SBIO's largest sub-industry exposure is Biotechnology at 81.5%, followed by Pharmaceuticals at 14.5%.

Biotechnology
81.5%
Pharmaceuticals
14.5%
Life Sciences Tools & Services
1.3%
Renewable Energy Equipment
0.6%
Health Care Services
0.4%
Health Care Equipment
0.3%

Related Companies and Tools

Related Companies

This page (NYSEARCA:SBIO) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ALPS Medical Breakthroughs ETF (SBIO) Holdings List